PPP2R5D

Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform · Q14738 · PPP2R5D on Sugi Atlas →

0 patent compounds predicted against PPP2R5D, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PPP2R5D by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis PHASE4COMPLETED
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt PHASE4COMPLETED
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds PHASE2/PHASE3COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome PHASE1/PHASE2COMPLETED
Open-label Study on Treatment of Primary Aldosteronism With Everolimus PHASE2COMPLETED
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2COMPLETED
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients PHASE1/PHASE2WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Bioequivalence Study of Tacrolimus in Healthy Volunteers PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Immune Signature of Palmoplantar Pustulosis nanCOMPLETED
NGS in Gallbladder Cancer and Response to Treatment nanRECRUITING
Severe Insulin Resistance in Patients With Type 2 Diabetes nanCOMPLETED
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 nanCOMPLETED
Studying Phosphorus Metabolism nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer nanCOMPLETED
Study of Metabolic Modifications in Children With Noonan Syndrome nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PPP2R5D binder may also engage these)

ProteinNameSimilarity
Q28653 1.000 Q28653 →
O18178 1.000 O18178 →
Q6PD03 1.000 Q6PD03 →
A4FV68 1.000 A4FV68 →
PPP2R5A Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform 1.000 landscape →
Q60996 1.000 Q60996 →
Q28651 1.000 Q28651 →
Q16537 1.000 Q16537 →
Q8RW96 1.000 Q8RW96 →
Q9SV41 0.999 Q9SV41 →
Q80W83 0.999 Q80W83 →
Q61151 0.999 Q61151 →
Q13362 0.998 Q13362 →
Q9LVE2 0.997 Q9LVE2 →
Q6PD28 0.997 Q6PD28 →
Q9ZQY6 0.997 Q9ZQY6 →
O04376 0.996 O04376 →
O54774 0.996 O54774 →
Q10428 0.996 Q10428 →
Q6I621 0.996 Q6I621 →
Q15173 0.996 Q15173 →
Q93YV6 0.996 Q93YV6 →
O04375 0.996 O04375 →
Q2KI89 0.995 Q2KI89 →
Q8LF36 0.995 Q8LF36 →
Q7Z3E5 0.995 Q7Z3E5 →
A0JMA8 0.995 A0JMA8 →
Q7ZYV9 0.995 Q7ZYV9 →
AP3D1 AP-3 complex subunit delta-1 0.994 landscape →
Q5XG71 0.994 Q5XG71 →